论文信息 - Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma - 字舞流文

Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma

P. Hari | N. Callander | E. Medvedova | R. Cornell | Aric Hall | A. D’Souza | L. Costa | S. Chhabra | B. Dhakal | B. Dholaria | R. Silbermann | S. Bal | J. Omel | K. Godby | T. Schmidt | S. Giri | Pamela Hardwick | Smith Giri